-
Something wrong with this record ?
Gait and Balance Impairment after Acute Methanol Poisoning
K. Peterová, H. Brožová, J. Klempíř, I. Lišková, O. Bezdicek, P. Ridzoň, M. Vaněčková, S. Zakharov, D. Pelclová, M. Miovský, E. Růžička,
Language English Country England, Great Britain
Document type Journal Article
Grant support
NV16-27075A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
Medline Complete (EBSCOhost)
from 2004-01-01 to 1 year ago
PubMed
28724204
DOI
10.1111/bcpt.12853
Knihovny.cz E-resources
- MeSH
- Gait drug effects MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Methanol poisoning MeSH
- Brain diagnostic imaging drug effects MeSH
- Nervous System Diseases chemically induced diagnosis epidemiology MeSH
- Neuroimaging methods MeSH
- Postural Balance drug effects MeSH
- Survivors statistics & numerical data MeSH
- Solvents poisoning MeSH
- Aged MeSH
- Walk Test MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic epidemiology MeSH
Neurological sequelae including gait impairment were reported in survivors after methanol intoxication; however, no systematic study has been published so far. We aimed to analyse gait and balance impairment in a group of Czech methanol poisoning survivors. We examined 43 patients (age 46 ± 13 years) 2-8 months after methanol poisoning and 43 healthy controls. Investigations contained a shortened version of Falls Efficacy Scale (FES), clinical tests of gait and balance including Timed Up and Go test (TUG) and gait analysis using GaitRite® system, neurological and neuropsychological examination, brain imaging, EMG and tests of alcohol consumption. Nineteen patients admitted balance and gait impairment according to FES. Mild to moderate parkinsonian signs showed seven patients. Patients were slower (8.8 versus 5.7 s, p < 0.001) and performed more steps (11.1 versus 7.9, p < 0.001) in TUG compared with the controls. Gait analysis revealed shorter step length (76.5 versus 88.7 cm, p < 0.001), increased double support phase (18.8 versus 15.5%, p < 0.001) and wider base of support (11.3 versus 9.6 cm, p = 0.006) in patients. Eleven patients had deficit of executive function and performed higher cadence compared to the patients with normal execution (122.7 versus 115.0 step/min., p = 0.025). Lower limb polyneuropathy was verified in nine patients, without relation with gait or balance parameters. Neuroimaging revealed lesions mainly in the basal ganglia. Methanol poisoning survivors presented slower wide-based gait with shortened steps corresponding with frontal gait disorder. Higher stepping cadence associated with executive deficit supported the evidence of frontal lobe dysfunction related to impairment of basal ganglia and connections in frontal cortico-basal ganglia loops.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033820
- 003
- CZ-PrNML
- 005
- 20240308091128.0
- 007
- ta
- 008
- 181008s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/bcpt.12853 $2 doi
- 035 __
- $a (PubMed)28724204
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Peterová, Kamila $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 245 10
- $a Gait and Balance Impairment after Acute Methanol Poisoning / $c K. Peterová, H. Brožová, J. Klempíř, I. Lišková, O. Bezdicek, P. Ridzoň, M. Vaněčková, S. Zakharov, D. Pelclová, M. Miovský, E. Růžička,
- 520 9_
- $a Neurological sequelae including gait impairment were reported in survivors after methanol intoxication; however, no systematic study has been published so far. We aimed to analyse gait and balance impairment in a group of Czech methanol poisoning survivors. We examined 43 patients (age 46 ± 13 years) 2-8 months after methanol poisoning and 43 healthy controls. Investigations contained a shortened version of Falls Efficacy Scale (FES), clinical tests of gait and balance including Timed Up and Go test (TUG) and gait analysis using GaitRite® system, neurological and neuropsychological examination, brain imaging, EMG and tests of alcohol consumption. Nineteen patients admitted balance and gait impairment according to FES. Mild to moderate parkinsonian signs showed seven patients. Patients were slower (8.8 versus 5.7 s, p < 0.001) and performed more steps (11.1 versus 7.9, p < 0.001) in TUG compared with the controls. Gait analysis revealed shorter step length (76.5 versus 88.7 cm, p < 0.001), increased double support phase (18.8 versus 15.5%, p < 0.001) and wider base of support (11.3 versus 9.6 cm, p = 0.006) in patients. Eleven patients had deficit of executive function and performed higher cadence compared to the patients with normal execution (122.7 versus 115.0 step/min., p = 0.025). Lower limb polyneuropathy was verified in nine patients, without relation with gait or balance parameters. Neuroimaging revealed lesions mainly in the basal ganglia. Methanol poisoning survivors presented slower wide-based gait with shortened steps corresponding with frontal gait disorder. Higher stepping cadence associated with executive deficit supported the evidence of frontal lobe dysfunction related to impairment of basal ganglia and connections in frontal cortico-basal ganglia loops.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a mozek $x diagnostické zobrazování $x účinky léků $7 D001921
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a chůze (způsob) $x účinky léků $7 D005684
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methanol $x otrava $7 D000432
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nemoci nervového systému $x chemicky indukované $x diagnóza $x epidemiologie $7 D009422
- 650 _2
- $a neurozobrazování $x metody $7 D059906
- 650 _2
- $a posturální rovnováha $x účinky léků $7 D004856
- 650 _2
- $a rozpouštědla $x otrava $7 D012997
- 650 _2
- $a přežívající $x statistika a číselné údaje $7 D017741
- 650 _2
- $a test chůzí $7 D000070857
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Brožová, Hana $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Klempíř, Jiří $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Ryšánková, Irena $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic. $7 xx0229048
- 700 1_
- $a Bezdicek, Ondřej $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Ridzoň, Petr $u Department of Occupational Medicine, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic. Department of Neurology, Thomayer Hospital, Prague, Czech Republic.
- 700 1_
- $a Vaněčková, Manuela $u Department of Radiology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Zakharov, Sergej $u Department of Occupational Medicine, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Pelclová, Daniela $u Department of Occupational Medicine, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Miovský, Michal $u Department of Addictology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Růžička, Evžen $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00007578 $t Basic & clinical pharmacology & toxicology $x 1742-7843 $g Roč. 122, č. 1 (2018), s. 176-182
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28724204 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20240308091121 $b ABA008
- 999 __
- $a ok $b bmc $g 1340310 $s 1030814
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 122 $c 1 $d 176-182 $e 20170906 $i 1742-7843 $m Basic & clinical pharmacology & toxicology $n Basic Clin Pharmacol Toxicol $x MED00007578
- GRA __
- $a NV16-27075A $p MZ0
- LZP __
- $a Pubmed-20181008